News
A University of Arizona cancer research lab, facing difficulties in getting federal funding, has started a crowdfunding campaign to raise money for its work.
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...
Thailand has introduced its first domestically created targeted therapy pill for cancer treatment, named Imcranib 100.
Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...
16h
Bangkok Post on MSNThailand produces its first targeted cancer drugThailand has produced its first locally developed targeted therapy pill for cancer treatment. Imcranib 100 is the result of the scientific vision and leadership of Her Royal Highness Princess ...
Prescription price controls and importing inferior medications will hurt both patients and America’s standards. We should ...
10h
News-Medical.Net on MSNLong-term survival achieved in stage III melanoma with pre-surgery immunotherapyFour years after pre-surgery treatment with a novel combination of immune checkpoint inhibitors, nivolumab and relatlimab, 87 ...
Opinion
20hOpinion
The New Times on MSNSubstandard cancer drugs a global scandal and public health emergency for LMICsThe recent revelation that nearly 20% of tested chemotherapy drugs failed basic quality standards is more than just alarming. It is a global public health crisis with devastating consequences, ...
Kuick Research Report highlights ongoing Clinical Development Technology platforms In Recent Research Study On KIF18A ...
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast ...
Former Costa Rican Minister Celso Gamboa faces U.S. extradition on charges of conspiring in international cocaine trafficking ...
"For decades, menopause has been overlooked in both clinical research and health care policy, largely because it affects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results